California’s first Road to the Kentucky Derby qualifier of 2026 is Saturday’s $100,000 Robert B. Lewis (G3) at Santa Anita.

The collaboration builds on Essential3 for Essential Tremor, extending support to the ENERGY programme.

Praxis Solutions ("Praxis") and ATTOM today announced the completion of a strategic initiative led by Praxis focused on identifying and prioritizing AI-driven growth opportunities that expand and ...

The award-winning exam prep partner is offering a guided challenge for anyone looking to replace resolutions with consistency and focus on study progress rather than perfection. Challenge enrollment ...

Industry leading education provider releases free resource to help aspiring agents navigate the California real estate ...

A total of 42 Road to the Kentucky Derby qualification points will be awarded in Friday’s $200,000 Withers S. at Aqueduct.

BOSTON - Praxis Precision Medicines, Inc. (NASDAQ:PRAX) announced Tuesday it will immediately convert its EMBRAVE3 registrational study for elsunersen in SCN2A developmental and epileptic ...

Having already claimed a win for the phase 2 study of its seizure drug, Praxis Precision Medicines is hoping fresh efficacy data will form the backbone of an approval application for the sodium ...

Investing.com -- Praxis Precision Medicines (NASDAQ:PRAX) stock surged 25% after the company announced its EMBOLD study evaluating relutrigine was stopped early due to positive efficacy results. The ...

Praxis Precision (PRAX) announced results from the registrational cohort of the EMBOLD study evaluating relutrigine for the treatment of patients with SCN2A and SCN8A developmental and epileptic ...

BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...

Praxis confirms an upcoming meeting with the FDA to discuss the results and NDA path BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage ...